CA2085975C - Dentinal desensitizing compositions - Google Patents
Dentinal desensitizing compositionsInfo
- Publication number
- CA2085975C CA2085975C CA002085975A CA2085975A CA2085975C CA 2085975 C CA2085975 C CA 2085975C CA 002085975 A CA002085975 A CA 002085975A CA 2085975 A CA2085975 A CA 2085975A CA 2085975 C CA2085975 C CA 2085975C
- Authority
- CA
- Canada
- Prior art keywords
- oral composition
- agent
- desensitizing
- weight
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Abstract
A composition containing a water soluble or water swellable polyelectrolyte or salts thereof in a dentifrice base or other oral compositions which can be used for relieving pain and discomfort caused by hypersensitive teeth. The salts can be single or mixed partial salts of the polyelectrolyte.
Description
D~:N'1'1~AL DESENSITIZING COMPOSITIONS
Hypersensitive teeth can cause pain and discomfort when subjected to changes in temperature, pressure, or chemical action. EX~G~U~ e of the dentln frequently leads to hypersensitivity. Dentin exposure may occur due to recession of the gums, periodontal disease and improper dental care. The usual method of treating hypersensitive teeth employs a desensitizing dentifrice or solution. Some of the active ingredients used in desensitizing dentifrices include strontium chloride, strontium acetate, potassium nitrate, and potassium chloride. Other treatments are applied professionally as a solution. These include solutions of ferric oxalate or potassium oxalate.
One approach to desensitization is to occlude exposed dentinal tubules. Dentinal tubules lead from the pulp to the surface of the dentin. When the surface of the tooth is eroded, the dentinal tubules become exposed to the external environment. The exposed dentinal tubules provide a pathway for transmlssion Of flui~ flow to the pulpal nerves and this is induced by changes in temperature, pressure and ionic gradients. By blocking the tubules, the external stimuli have a diminished effect, and less pain will be felt.
Some active ingredients, such as ferric oxalate, are known to form mineral deposits on the #194 '~ 208597~
surfaces of exposed dentinal tubules, effectively blocking the openings. In some cases, the abrasive action from brushing may cause a smear layer to form over the surface of the tooth and thus plug up the open tubules. The accumulation of particulate matter from the interstitial fluid passing through the dentinal tubules or remineralization within the tubules can cause a natural occlusion of the tubules.
Nerve inactivation is another mechanism whereby desensitization can occur. This relies on the action of an active ingredient such as potassium nitrate on the nerves. By altering the ionic balance in the nerve, the threshold of nerve stimulation is increased. Thus a higher level of stimulation is needed to evoke a painful response.
The materials which have been used as active ingredients in the treatment of hypersensitive teeth are generally inorganic salts or hydrophobic compounds.
Although hydrophilic polymers have been used in oral compositions as excipients or the like, they have not been suggested as being useful active ingredients for desensitization purposes. Most of the hydrophilic polymers have been used to control the viscosity of the oral formulation or to give it thixotropic properties.
An example of such a polymer is polyacrylic acid which is used as a thickener in dentifrice formulations. It has also been used in gels, mouthwashes and buccal adhesive patches. However, polyacrylic acid has also been used for other purposes. For example, Leonard et al. (U.S. Patent 5,011,830) state an oral ~Y194 2~85975 composition containing an alkali pyrophosphate salt, a fluoride salt and a polyacrylic acid or a copolymer of acrylic acid and another monomer can provide P~hAn~
anti-calculus benefits. Gaffar (U.S. Patent 3,956,480) uses an anionic polymer such as polyacrylic acid with chlorhexidine as an anti-calculus agent. Benedict and Sunberg (U.S. Patent 4,661,341) describe the use of polyacrylic acid or copolymers of polyacrylic acid as anti-calculus agents.
Another polymer which is used in oral compositions is the copolymer of methyl vinyl ether and maleic anhydride (MVE/MA) or the hydrolyzed acid copolymer. The MVE/MA copolymer and its salts have been used to enhance anti-calculus, anti-plaque, and anti-caries activity, and to control mouth odor. It has also been used to stabilize active agents in dentifrice formulations.
Suhonen (U.S. Pat. 4,960,586; 4,961,924) uses the MVEIMA copolymer to stabilize stannous fluoride dentifrice compositions.
Gaffar et al. (U.S. Pat. 4,138,477) use a zinc compound with the MVE/MA copolymer in a composition to control mouth odor and also to prevent calculus, caries, plaque, and periodontal disease.
Wietfeldt (U.S. Pat. 4,965,067) uses the MVE/MA
copolymer, a soluble fluoride ion source, and a strontium ion source in a dentifrice composition. The polymer is said to stabilize the combination of strontium and fluoride in the composition which will form a precipitate without stabilization.
#194 7 ~
Friedman (EP 0381445) claims an oral composition with an anti-hypersensitivity agent such as strontium chloride in a hyd~o~hobic polymer which can be applied to the teeth. The polymer matrix has an affinity for the teeth and acts as a matrix for the sustained release of the active ingredient. An example of a carrier used is ethyl cellulose with polyethylene glycol as a plasticizer.
Mason (U.S. Pat. 4,992,258J discloses the use of montmorillonite clay and a MVE/MA copolymer in a dentifrice formulation for the treatment of hypersensitive teeth. It is asserted in this patent that the MVE/MA copolymer increases the effectiveness of the montmorillonite clay.
lS In none of the examples above or elsewhere, as far as we are aware, are these polymers claimed to provide a desensitizing effect. Even in the Mason patent where a MVE/MA copolymer was used to increase the effectiveness of a ~eC~citizing agent there is no attribution of such properties to the polymer.
Zinner et al., A New Desensitizing Dentrifice:Preliminary Report, JADA, Vol. 95 pp. 982-985, November 1977 reports that a Pluronic F127 based dentrifice, with or without sodium citrate, had some desensitizing efficacy. Pluronic F127 is a non-ionic water soluble copolymer of ethylene oxide and propylene oxide.
It has now been determined that water soluble or water swellable polyelectrolytes, i.e. polymers with functional groups that are capable of bearing one or more *Trademark 2~S5975 charged groups in an aqueous solution have desensitizing properties.
It is accordingly the object of this invention to provide new dentinal desensitizing agents. This and other objects of the invention will become apparent to those skilled in this art from the following detailed description.
This invention relates to an oral composition and method which is useful for relieving pain and discomfort caused by hypersensitive teeth. More particularly, the invention relates to the use of a water soluble or water swellable polyelectrolyte or the partial salts thereof as a dental desensitization agent. The cations used to make the salt can include ammoniùm, alkylammonium, calcium, sodium, potassium, strontium, magnesium, zinc, aluminum, tin, iron, barium, lanthanum, titanium, bismuth and copper. The salts may contain single cations or mixed cations.
The polymer and its salts may be formulated into a dentifrice, gel, buccal adhesive patch, mouthwash, lozenge, or gum. Use of these oral compositions on a regular basis can provide relief from the pain and discomfort of hypersensitive teeth. The oral composition described above may also provide for a sustained release mode of action for the delivery of strontium or potassium ions from the water soluble or water swellable polyelectrolytes. The polyelectrolytes may also be used in conjunction with additional desensitizing agents such #194 2~)8597~3 as strontium chloride or potassium nitrate in an oral composltion .
In accordance with the present invention, a water soluble or water swellable polyelectrolyte is used as a dentinal desensitizing agent. The agent can be - incorporated into a dentrifice, gel, mouthwash, lozenge, buccal adhesive patch, gum or the like. The water soluble or swellable polymers are generally polyelectrolytes, that is, polymers which bear one or more functional groups capable of bearing a charge in an aqueous medium. These polyelectrolytes can be anionic, cationic or amphoteric.
one example of an anionic functional group is the carboxylate group. This group is found in such polymers as polyacrylic acid, copolymers of acrylic acid and maleic acid, copolymers of methacrylic acid and acrylic acid, copolymers of alkyl vinyl ethers and maleic acid or anhydride, and the like. In the alkyl vinyl ether/maleic acid or anhydride copolymers, the alkyl group generally contains 1 to about 10 carbon atoms and is most preferably a methyl group. The copolymer can be produced using procedures well known in the art or commercially available forms can be employed. For instance, the methyl vinyl ether/maleic anhydride copolymer can be obtained from International Specialty Products under the tradename Gantrez~ - AN or as the hydrolyzed acid under the tradename Gantrez~ - S.
Polyacrylic acid can be obtained from B.F. Goodrich under #194 2u8s97s the tradename Carbopol0 or Noveon~ as a cross-linked polyacrylic acid. Polyacrylic acid can also be obt~in~A
from Rohm and Haas under the tradename Acusol~. These and other usable anionic polyelectrolytes are available from various other manufacturers. Another anionic functional group is the sulfonate group which is found for instance in sodium polystyrene sulfonate polymers.
The polyelectrolytes can contain cationic functional groups such as quaternized amines, imines, amides and alkyl ammonium groups. Examples include copolymers of vinyl pyrrolidone and dialkyl aminoalkyl methacrylates, chitosan, cationic celluloses and the like. A copolymer of vinyl pyrrolidone and dialkyl aminoalkyl methacrylate is available from International Specialty Products under the tradename Gafquat~.
Chitosan is available under various tradenames from several companies.
Amphoteric polymers can also be used as a dentinal desensitizing agent. Examples include the aminoalkyl methacrylate and acrylates, copolymers of aminoalkyl acrylamides and acrylates, gelatin and the like.
The foregoing polymers are illustrative. The main criteria are that the polymer is water soluble or water swellable and contains functional groups capable of bearing a charge.
The commercially available polymers are produced over a range of molecular weights. ThUs, for instance, Gantrez~ - AN is available as a high molecular weight grade (Gantrez~ - AN-179 MW=80,000) down to a low #194 208~975 ,~
molecular weight grade (Gantrez~ AN-119 MW=30,000).
Similarly, Carbopol~ and Noveon~ are available in different grades with different rheological properties.
The different grades range in molecular weight from 5 450,000 (907 type) to 4,000,000 (940 type). It is preferable to employ the highest molecular weight grade consistent with the viscosity of the formulation being prepared and concentration of the agent. The formulations will contain a desensitizing amount which is generally of from about 0.1% to 30% by weight of the polymer or its partial salts, with about 1-15% being preferred and about 2-12% most preferred. For any given concentration, viscosity generally increases with molecular weight and for any given molecular weight, viscosity generally increases with concentration.
The properties of some of these polymers may be modified to obtain the most advantageous properties by neutralization or partial neutralization. The cation may be present in the salts at about 20% to 100% equivalent mole ratio of the polymer. The preferred range is from about 40% to 90% equivalent of the polymer. The cations that can be used include ammonium, alkylammonium, calcium, sodium, potassium, strontium, zinc, aluminum, magnesium, tin, iron, barium, lanthanum, titanium, bismuth and copper. The cations can be used singly or as a mixture of different cations. These salts as such are well known in the art.
The salts of the copolymer can be made by making a solution of the polymer in water and then adding a metal salt such as the hydroxide, carbonate, ~Y194 bicarbonate, oxide, acetate, citrate, lactate or formate.
The metal salt is preferably alkaline. The solution is stirred, with heating if necessary, until the polymer has dissolved. It will usually have a pH between about 3.5 and 9, depending on the amount of metal salt used. The salt solution can be directly incorporated into an aqueous oral composition. Alternatively, the solution can be evaporated to dryness to give a solid salt which can be milled to a fine powder, if desired, and incorporated into an oral composition.
The polymer or its salts can be formulated into a dentifrice, mouthwash, lozenge, buccal adhesive patch or gum using ingredients and procedures which are well known and commonly used in preparing these oral compositions. By way of example, without limitation, it is possible to incorporate a fluoride source into the oral composition. Of course, the ingredients used to make the above oral compositions should be compatible with the polymer and its salts. It is also possible to formulate the oral compositions in conjunction with additional desensitizing agents. Additional desensitizing agents include, without limitation, sodium fluoride, sodium silicofluoride, zinc chloride, formaldehyde, glycerin and silver nitrate. Additional desensitizing agents may also include potassium-containing compounds, such as potassium nitrate, as described in U.S. Patent 3,863,006 and strontium-containing compounds, such as strontium chloride, as described in U.S. Patent 3,122,483.
~194 The polyelectrolytes have an affinity for the tooth surface and can maintain their presence over a period of time. During that period, the MVE/MA copolymer salts that contain potassium or strontium or other actives can slowly release the ions into the oral environment. This allows for a longer term availability of the actives for desensitization.
In order to further illustrate the present invention, various non-limiting examples are set forth below. In these examples, as throughout this specification and claims, all temperatures are in degrees centigrade and all parts and percentages are by weight unless otherwise indicated.
Exam~le 1 A dispersion of 156g Gantrez~ AN-169 (MW=67,000) in 1.8 liters of water was stirred vigorously with heating and a slurry of 133g strontium hydroxide, octahydrate in 320g of water was slowly added to the mixture. The mixture was heated to 90~C whereupon it started to become clear. Then the solution was allowed to cool to 70~C and stirred at that temperature for an additional 2 hours. A 9% solution of a strontium (50%
equivalent) MVE/MA salt was thus obtained. This solution was used as is or was evaporated to dryness and then milled to a fine powder.
Example 2 A 12% solution of a potassium (40% equivalent) salt of the MVE/MA copolymer was made using 156g of Gantrez~ AN-169 and 45g of potassium hydroxide in 1.5 liters of water following the procedure in Example 1.
#194 2 1)~59~5 This solution was used to make a dentifrice using the following ingredients:
INGREDIENT % WEIGHT
12% Solution of MVE/MA 60.3%
(40% equivalent potassium salt) Sorbitol 11.4%
Glycerin 12.0%
Carboxymethyl cellulose2.4%
Diatomaceous earth 10.1%
Sodium lauryl sulfate (SLS) 0.6%
TiO2 1. 0%
Fumed silica 1.6%
Flavor and preservative0.6%
The dentifrice was made by mixing the 12% solution of the partial potassium (40% equivalent) MVE/MA salt, sorbitol, glycerin, silica, SLS, and Tio2 together. After mixing, the carboxymethyl cellulose was added and blended into a homogeneous mixture.
Example 3 A dentifrice was prepared from:
INGREDIENT % WEIGHT
6% Solution of MVE/MA60.3%
(80% equivalent sodium salt) Tio~ 1. 0%
Sorbitol 12%
Fumed silica 1.6%
caC03 10. 1%
Glycerin 12%
Carboxymethyl cellulose2.4%
SLS 0.6%
#194 1_ 208597~
The dentifrice is made in a manner similar to that described in Example 2.
ExamDle 4 A gel containing a sodium (80% equivalent) salt 5 of polyacrylic acid was prepared from the following ingredients:
INGREDIENT % WEIGHT
Polyacrylic Acid 2.9%
Sodium hydroxide 1.3%
Glycerine 21.0%
Potassium Nitrate 5.0%
Water 69.8%
Exam~le 5 A dentrifice containing a 5% polyacrylic acid 15 (80% equivalent sodium salt) was prepared from the following ingredients:
INGREDIENT % WEIGHT
Polyacrylic Acid 4.0%
Sodium hydroxide 1.8%
Glycerin 20.0%
Potassium Nitrate 5.0%
Silica 3.9%
Pluronic F-87* 2.5%
Flavors & Preservatives0.7%
Water 62.1%
* Copolymer of ethylene oxide and propylene oxide Exam~le 6 A gel was prepared from the following ingredients:
#194 ~ 2~85~75 INGREDIENT % WEIGHT
Gelatin Type A 14.3%
Calcium chloride, dihydrate5.7%
Urea 5.7%
Water 74-3%
The pH was adjusted to 6.7 using sodium hydroxide.
Exam~le 7 A desensitizing solution was made from the following ingredients:
INGREDIENT % Weight Vinyl pyrrolidone/dimethyl-amino ethyl methacrylate copolymer 5%
Sodium chloride 0.6%
Water 94.4%
The pH was adjusted to 7.7.
Exam~le 8 A desensitizing gel was made from the following ingredients:
INGREDIENT % Weiqht Chitosan lactate 6%
Water 94%
The pH was adjusted to pH 5.
Exam~le 9 A desensitizing solution was made from the following ingredients:
INGREDIENT % Weight Poly (dimethyl diallyl-ammonium chloride) 6%
Sodium Chloride 0.6%
Water 93-4%
#194 208597~
Tests Of Oral Compositions Of Exam~les 1-9 The prepared solutions and oral compositions were tested using the method described by Pashley (J.
Periodontology, Vol. 55, No. 9, p. 522, Sept. 1984).
This test measures the flow of fluid through a sliced dentin disc. A treatment that will reduce the flow through the discs can also result in reduced dentinal hypersensitivity for people using the treatment.
A caries free tooth is sliced to obtain a 0.4 to 0.6 mm thick dentin disc. The disc is mounted on a split chamber device (J. Dent. Research 57:187, 1978).
The initial flow of fluid through the disc is measured, and then the disc is treated by brushing with one of the desensitizing treatments. After brushing, the flow rate is again measured and the reduction in flow is calculated from these measurements. The following compositions were used and the reduction in flow is reported. The results for the dentifrices are based on 1 to 1 dilution with artificial or human saliva.
Treatment % Chanqe in Flow Example 1 -43%
Example 2 -47%
Example 3 -39%
Example 4 -48%
Example 5 -63%
Example 6 -57%
Example 7 -80%
Example 8 -69%
Example 9 -59%
#194 - 208~975 Exam~le 10 A mouthwash was made by mixing the following ingredients:
INGREDIENT % WEIGHT
10.3% solution of NVE/MA
(90% equivalent sodium salt) 70%
Alcohol 190 Proof (Grain Alcohol) 10%
Pluronic F-127 2%
Flavor 0.3%
Menthol 0.02%
Water q.s. to 100%
Example 11 The following composition was used to make a chewing gum:
INGREDIENT % WEIGHT
Chewing gum NOVA Base "A" 24.64%
Glycerin 1%
Calcium saccharin 0.06%
Sorbitol powder 53.5%
Lycasin 13%
Lecithin 0.8%
Flavor 1%
Chitosan lactate 6%
25 The chewing gum base was softened at 65~C using a sigma blade mixer, cooled to 60~C and 3/5 of the sorbitol powder and calcium saccharin added, followed by the glycerin. Then 1/5 of the sorbitol powder, 1/2 of the lycasin and the chitosan were added. After cooling to #194 208597~
50~C, the rest of the sorbitol powder, lycasin, and flavor were added. The mixture was rolled into patties and cut into strips.
Exam~le 12 S The following composition was used to make a lozenge:
INGREDIENT % WEIGHT
Sorbitol 86.5%
Xylitol 6 %
Citric Acid 0.4%
Flavor 0.1 Gelatin 7 %
The sorbitol and xylitol were heated at 165~C until the base started to thicken. The combination was cooled to 140~C and the citric acid added. After cooling to 100~C, the gelatin was added and after cooling to 85~C, the flavor was added. Cooling was continued and a seed crystal of sorbitol was added to start crystallization.
The mixture was poured into molds to form lozenges.
Various changes and modifications can be made in the process and products of this invention without departing from the scope thereof. The various embodiments described herein were for the purpose of further illustrating the invention but were not intended to limit it.
~194
Hypersensitive teeth can cause pain and discomfort when subjected to changes in temperature, pressure, or chemical action. EX~G~U~ e of the dentln frequently leads to hypersensitivity. Dentin exposure may occur due to recession of the gums, periodontal disease and improper dental care. The usual method of treating hypersensitive teeth employs a desensitizing dentifrice or solution. Some of the active ingredients used in desensitizing dentifrices include strontium chloride, strontium acetate, potassium nitrate, and potassium chloride. Other treatments are applied professionally as a solution. These include solutions of ferric oxalate or potassium oxalate.
One approach to desensitization is to occlude exposed dentinal tubules. Dentinal tubules lead from the pulp to the surface of the dentin. When the surface of the tooth is eroded, the dentinal tubules become exposed to the external environment. The exposed dentinal tubules provide a pathway for transmlssion Of flui~ flow to the pulpal nerves and this is induced by changes in temperature, pressure and ionic gradients. By blocking the tubules, the external stimuli have a diminished effect, and less pain will be felt.
Some active ingredients, such as ferric oxalate, are known to form mineral deposits on the #194 '~ 208597~
surfaces of exposed dentinal tubules, effectively blocking the openings. In some cases, the abrasive action from brushing may cause a smear layer to form over the surface of the tooth and thus plug up the open tubules. The accumulation of particulate matter from the interstitial fluid passing through the dentinal tubules or remineralization within the tubules can cause a natural occlusion of the tubules.
Nerve inactivation is another mechanism whereby desensitization can occur. This relies on the action of an active ingredient such as potassium nitrate on the nerves. By altering the ionic balance in the nerve, the threshold of nerve stimulation is increased. Thus a higher level of stimulation is needed to evoke a painful response.
The materials which have been used as active ingredients in the treatment of hypersensitive teeth are generally inorganic salts or hydrophobic compounds.
Although hydrophilic polymers have been used in oral compositions as excipients or the like, they have not been suggested as being useful active ingredients for desensitization purposes. Most of the hydrophilic polymers have been used to control the viscosity of the oral formulation or to give it thixotropic properties.
An example of such a polymer is polyacrylic acid which is used as a thickener in dentifrice formulations. It has also been used in gels, mouthwashes and buccal adhesive patches. However, polyacrylic acid has also been used for other purposes. For example, Leonard et al. (U.S. Patent 5,011,830) state an oral ~Y194 2~85975 composition containing an alkali pyrophosphate salt, a fluoride salt and a polyacrylic acid or a copolymer of acrylic acid and another monomer can provide P~hAn~
anti-calculus benefits. Gaffar (U.S. Patent 3,956,480) uses an anionic polymer such as polyacrylic acid with chlorhexidine as an anti-calculus agent. Benedict and Sunberg (U.S. Patent 4,661,341) describe the use of polyacrylic acid or copolymers of polyacrylic acid as anti-calculus agents.
Another polymer which is used in oral compositions is the copolymer of methyl vinyl ether and maleic anhydride (MVE/MA) or the hydrolyzed acid copolymer. The MVE/MA copolymer and its salts have been used to enhance anti-calculus, anti-plaque, and anti-caries activity, and to control mouth odor. It has also been used to stabilize active agents in dentifrice formulations.
Suhonen (U.S. Pat. 4,960,586; 4,961,924) uses the MVEIMA copolymer to stabilize stannous fluoride dentifrice compositions.
Gaffar et al. (U.S. Pat. 4,138,477) use a zinc compound with the MVE/MA copolymer in a composition to control mouth odor and also to prevent calculus, caries, plaque, and periodontal disease.
Wietfeldt (U.S. Pat. 4,965,067) uses the MVE/MA
copolymer, a soluble fluoride ion source, and a strontium ion source in a dentifrice composition. The polymer is said to stabilize the combination of strontium and fluoride in the composition which will form a precipitate without stabilization.
#194 7 ~
Friedman (EP 0381445) claims an oral composition with an anti-hypersensitivity agent such as strontium chloride in a hyd~o~hobic polymer which can be applied to the teeth. The polymer matrix has an affinity for the teeth and acts as a matrix for the sustained release of the active ingredient. An example of a carrier used is ethyl cellulose with polyethylene glycol as a plasticizer.
Mason (U.S. Pat. 4,992,258J discloses the use of montmorillonite clay and a MVE/MA copolymer in a dentifrice formulation for the treatment of hypersensitive teeth. It is asserted in this patent that the MVE/MA copolymer increases the effectiveness of the montmorillonite clay.
lS In none of the examples above or elsewhere, as far as we are aware, are these polymers claimed to provide a desensitizing effect. Even in the Mason patent where a MVE/MA copolymer was used to increase the effectiveness of a ~eC~citizing agent there is no attribution of such properties to the polymer.
Zinner et al., A New Desensitizing Dentrifice:Preliminary Report, JADA, Vol. 95 pp. 982-985, November 1977 reports that a Pluronic F127 based dentrifice, with or without sodium citrate, had some desensitizing efficacy. Pluronic F127 is a non-ionic water soluble copolymer of ethylene oxide and propylene oxide.
It has now been determined that water soluble or water swellable polyelectrolytes, i.e. polymers with functional groups that are capable of bearing one or more *Trademark 2~S5975 charged groups in an aqueous solution have desensitizing properties.
It is accordingly the object of this invention to provide new dentinal desensitizing agents. This and other objects of the invention will become apparent to those skilled in this art from the following detailed description.
This invention relates to an oral composition and method which is useful for relieving pain and discomfort caused by hypersensitive teeth. More particularly, the invention relates to the use of a water soluble or water swellable polyelectrolyte or the partial salts thereof as a dental desensitization agent. The cations used to make the salt can include ammoniùm, alkylammonium, calcium, sodium, potassium, strontium, magnesium, zinc, aluminum, tin, iron, barium, lanthanum, titanium, bismuth and copper. The salts may contain single cations or mixed cations.
The polymer and its salts may be formulated into a dentifrice, gel, buccal adhesive patch, mouthwash, lozenge, or gum. Use of these oral compositions on a regular basis can provide relief from the pain and discomfort of hypersensitive teeth. The oral composition described above may also provide for a sustained release mode of action for the delivery of strontium or potassium ions from the water soluble or water swellable polyelectrolytes. The polyelectrolytes may also be used in conjunction with additional desensitizing agents such #194 2~)8597~3 as strontium chloride or potassium nitrate in an oral composltion .
In accordance with the present invention, a water soluble or water swellable polyelectrolyte is used as a dentinal desensitizing agent. The agent can be - incorporated into a dentrifice, gel, mouthwash, lozenge, buccal adhesive patch, gum or the like. The water soluble or swellable polymers are generally polyelectrolytes, that is, polymers which bear one or more functional groups capable of bearing a charge in an aqueous medium. These polyelectrolytes can be anionic, cationic or amphoteric.
one example of an anionic functional group is the carboxylate group. This group is found in such polymers as polyacrylic acid, copolymers of acrylic acid and maleic acid, copolymers of methacrylic acid and acrylic acid, copolymers of alkyl vinyl ethers and maleic acid or anhydride, and the like. In the alkyl vinyl ether/maleic acid or anhydride copolymers, the alkyl group generally contains 1 to about 10 carbon atoms and is most preferably a methyl group. The copolymer can be produced using procedures well known in the art or commercially available forms can be employed. For instance, the methyl vinyl ether/maleic anhydride copolymer can be obtained from International Specialty Products under the tradename Gantrez~ - AN or as the hydrolyzed acid under the tradename Gantrez~ - S.
Polyacrylic acid can be obtained from B.F. Goodrich under #194 2u8s97s the tradename Carbopol0 or Noveon~ as a cross-linked polyacrylic acid. Polyacrylic acid can also be obt~in~A
from Rohm and Haas under the tradename Acusol~. These and other usable anionic polyelectrolytes are available from various other manufacturers. Another anionic functional group is the sulfonate group which is found for instance in sodium polystyrene sulfonate polymers.
The polyelectrolytes can contain cationic functional groups such as quaternized amines, imines, amides and alkyl ammonium groups. Examples include copolymers of vinyl pyrrolidone and dialkyl aminoalkyl methacrylates, chitosan, cationic celluloses and the like. A copolymer of vinyl pyrrolidone and dialkyl aminoalkyl methacrylate is available from International Specialty Products under the tradename Gafquat~.
Chitosan is available under various tradenames from several companies.
Amphoteric polymers can also be used as a dentinal desensitizing agent. Examples include the aminoalkyl methacrylate and acrylates, copolymers of aminoalkyl acrylamides and acrylates, gelatin and the like.
The foregoing polymers are illustrative. The main criteria are that the polymer is water soluble or water swellable and contains functional groups capable of bearing a charge.
The commercially available polymers are produced over a range of molecular weights. ThUs, for instance, Gantrez~ - AN is available as a high molecular weight grade (Gantrez~ - AN-179 MW=80,000) down to a low #194 208~975 ,~
molecular weight grade (Gantrez~ AN-119 MW=30,000).
Similarly, Carbopol~ and Noveon~ are available in different grades with different rheological properties.
The different grades range in molecular weight from 5 450,000 (907 type) to 4,000,000 (940 type). It is preferable to employ the highest molecular weight grade consistent with the viscosity of the formulation being prepared and concentration of the agent. The formulations will contain a desensitizing amount which is generally of from about 0.1% to 30% by weight of the polymer or its partial salts, with about 1-15% being preferred and about 2-12% most preferred. For any given concentration, viscosity generally increases with molecular weight and for any given molecular weight, viscosity generally increases with concentration.
The properties of some of these polymers may be modified to obtain the most advantageous properties by neutralization or partial neutralization. The cation may be present in the salts at about 20% to 100% equivalent mole ratio of the polymer. The preferred range is from about 40% to 90% equivalent of the polymer. The cations that can be used include ammonium, alkylammonium, calcium, sodium, potassium, strontium, zinc, aluminum, magnesium, tin, iron, barium, lanthanum, titanium, bismuth and copper. The cations can be used singly or as a mixture of different cations. These salts as such are well known in the art.
The salts of the copolymer can be made by making a solution of the polymer in water and then adding a metal salt such as the hydroxide, carbonate, ~Y194 bicarbonate, oxide, acetate, citrate, lactate or formate.
The metal salt is preferably alkaline. The solution is stirred, with heating if necessary, until the polymer has dissolved. It will usually have a pH between about 3.5 and 9, depending on the amount of metal salt used. The salt solution can be directly incorporated into an aqueous oral composition. Alternatively, the solution can be evaporated to dryness to give a solid salt which can be milled to a fine powder, if desired, and incorporated into an oral composition.
The polymer or its salts can be formulated into a dentifrice, mouthwash, lozenge, buccal adhesive patch or gum using ingredients and procedures which are well known and commonly used in preparing these oral compositions. By way of example, without limitation, it is possible to incorporate a fluoride source into the oral composition. Of course, the ingredients used to make the above oral compositions should be compatible with the polymer and its salts. It is also possible to formulate the oral compositions in conjunction with additional desensitizing agents. Additional desensitizing agents include, without limitation, sodium fluoride, sodium silicofluoride, zinc chloride, formaldehyde, glycerin and silver nitrate. Additional desensitizing agents may also include potassium-containing compounds, such as potassium nitrate, as described in U.S. Patent 3,863,006 and strontium-containing compounds, such as strontium chloride, as described in U.S. Patent 3,122,483.
~194 The polyelectrolytes have an affinity for the tooth surface and can maintain their presence over a period of time. During that period, the MVE/MA copolymer salts that contain potassium or strontium or other actives can slowly release the ions into the oral environment. This allows for a longer term availability of the actives for desensitization.
In order to further illustrate the present invention, various non-limiting examples are set forth below. In these examples, as throughout this specification and claims, all temperatures are in degrees centigrade and all parts and percentages are by weight unless otherwise indicated.
Exam~le 1 A dispersion of 156g Gantrez~ AN-169 (MW=67,000) in 1.8 liters of water was stirred vigorously with heating and a slurry of 133g strontium hydroxide, octahydrate in 320g of water was slowly added to the mixture. The mixture was heated to 90~C whereupon it started to become clear. Then the solution was allowed to cool to 70~C and stirred at that temperature for an additional 2 hours. A 9% solution of a strontium (50%
equivalent) MVE/MA salt was thus obtained. This solution was used as is or was evaporated to dryness and then milled to a fine powder.
Example 2 A 12% solution of a potassium (40% equivalent) salt of the MVE/MA copolymer was made using 156g of Gantrez~ AN-169 and 45g of potassium hydroxide in 1.5 liters of water following the procedure in Example 1.
#194 2 1)~59~5 This solution was used to make a dentifrice using the following ingredients:
INGREDIENT % WEIGHT
12% Solution of MVE/MA 60.3%
(40% equivalent potassium salt) Sorbitol 11.4%
Glycerin 12.0%
Carboxymethyl cellulose2.4%
Diatomaceous earth 10.1%
Sodium lauryl sulfate (SLS) 0.6%
TiO2 1. 0%
Fumed silica 1.6%
Flavor and preservative0.6%
The dentifrice was made by mixing the 12% solution of the partial potassium (40% equivalent) MVE/MA salt, sorbitol, glycerin, silica, SLS, and Tio2 together. After mixing, the carboxymethyl cellulose was added and blended into a homogeneous mixture.
Example 3 A dentifrice was prepared from:
INGREDIENT % WEIGHT
6% Solution of MVE/MA60.3%
(80% equivalent sodium salt) Tio~ 1. 0%
Sorbitol 12%
Fumed silica 1.6%
caC03 10. 1%
Glycerin 12%
Carboxymethyl cellulose2.4%
SLS 0.6%
#194 1_ 208597~
The dentifrice is made in a manner similar to that described in Example 2.
ExamDle 4 A gel containing a sodium (80% equivalent) salt 5 of polyacrylic acid was prepared from the following ingredients:
INGREDIENT % WEIGHT
Polyacrylic Acid 2.9%
Sodium hydroxide 1.3%
Glycerine 21.0%
Potassium Nitrate 5.0%
Water 69.8%
Exam~le 5 A dentrifice containing a 5% polyacrylic acid 15 (80% equivalent sodium salt) was prepared from the following ingredients:
INGREDIENT % WEIGHT
Polyacrylic Acid 4.0%
Sodium hydroxide 1.8%
Glycerin 20.0%
Potassium Nitrate 5.0%
Silica 3.9%
Pluronic F-87* 2.5%
Flavors & Preservatives0.7%
Water 62.1%
* Copolymer of ethylene oxide and propylene oxide Exam~le 6 A gel was prepared from the following ingredients:
#194 ~ 2~85~75 INGREDIENT % WEIGHT
Gelatin Type A 14.3%
Calcium chloride, dihydrate5.7%
Urea 5.7%
Water 74-3%
The pH was adjusted to 6.7 using sodium hydroxide.
Exam~le 7 A desensitizing solution was made from the following ingredients:
INGREDIENT % Weight Vinyl pyrrolidone/dimethyl-amino ethyl methacrylate copolymer 5%
Sodium chloride 0.6%
Water 94.4%
The pH was adjusted to 7.7.
Exam~le 8 A desensitizing gel was made from the following ingredients:
INGREDIENT % Weiqht Chitosan lactate 6%
Water 94%
The pH was adjusted to pH 5.
Exam~le 9 A desensitizing solution was made from the following ingredients:
INGREDIENT % Weight Poly (dimethyl diallyl-ammonium chloride) 6%
Sodium Chloride 0.6%
Water 93-4%
#194 208597~
Tests Of Oral Compositions Of Exam~les 1-9 The prepared solutions and oral compositions were tested using the method described by Pashley (J.
Periodontology, Vol. 55, No. 9, p. 522, Sept. 1984).
This test measures the flow of fluid through a sliced dentin disc. A treatment that will reduce the flow through the discs can also result in reduced dentinal hypersensitivity for people using the treatment.
A caries free tooth is sliced to obtain a 0.4 to 0.6 mm thick dentin disc. The disc is mounted on a split chamber device (J. Dent. Research 57:187, 1978).
The initial flow of fluid through the disc is measured, and then the disc is treated by brushing with one of the desensitizing treatments. After brushing, the flow rate is again measured and the reduction in flow is calculated from these measurements. The following compositions were used and the reduction in flow is reported. The results for the dentifrices are based on 1 to 1 dilution with artificial or human saliva.
Treatment % Chanqe in Flow Example 1 -43%
Example 2 -47%
Example 3 -39%
Example 4 -48%
Example 5 -63%
Example 6 -57%
Example 7 -80%
Example 8 -69%
Example 9 -59%
#194 - 208~975 Exam~le 10 A mouthwash was made by mixing the following ingredients:
INGREDIENT % WEIGHT
10.3% solution of NVE/MA
(90% equivalent sodium salt) 70%
Alcohol 190 Proof (Grain Alcohol) 10%
Pluronic F-127 2%
Flavor 0.3%
Menthol 0.02%
Water q.s. to 100%
Example 11 The following composition was used to make a chewing gum:
INGREDIENT % WEIGHT
Chewing gum NOVA Base "A" 24.64%
Glycerin 1%
Calcium saccharin 0.06%
Sorbitol powder 53.5%
Lycasin 13%
Lecithin 0.8%
Flavor 1%
Chitosan lactate 6%
25 The chewing gum base was softened at 65~C using a sigma blade mixer, cooled to 60~C and 3/5 of the sorbitol powder and calcium saccharin added, followed by the glycerin. Then 1/5 of the sorbitol powder, 1/2 of the lycasin and the chitosan were added. After cooling to #194 208597~
50~C, the rest of the sorbitol powder, lycasin, and flavor were added. The mixture was rolled into patties and cut into strips.
Exam~le 12 S The following composition was used to make a lozenge:
INGREDIENT % WEIGHT
Sorbitol 86.5%
Xylitol 6 %
Citric Acid 0.4%
Flavor 0.1 Gelatin 7 %
The sorbitol and xylitol were heated at 165~C until the base started to thicken. The combination was cooled to 140~C and the citric acid added. After cooling to 100~C, the gelatin was added and after cooling to 85~C, the flavor was added. Cooling was continued and a seed crystal of sorbitol was added to start crystallization.
The mixture was poured into molds to form lozenges.
Various changes and modifications can be made in the process and products of this invention without departing from the scope thereof. The various embodiments described herein were for the purpose of further illustrating the invention but were not intended to limit it.
~194
Claims (10)
1. In an oral composition containing a desensitizing agent, the improvement which comprises the desensitizing agent being at least one water soluble or water swellable polyelectrolyte.
2. The oral composition of claim 1 wherein the polyelectrolyte contains a functional group selected from the group consisting of carboxylate, carboxy, amino alkylammonium and mixtures thereof.
3. The oral composition of claim 1 in which the agent contains a carboxyl functional group or the sale of the carboxyl functional group having a degree of neutralization from about 20 to 100% in which the cation is selected from the group consisting of ammonium, alkylammonium, calcium, sodium, potassium, strontium, zinc, aluminum, manganese, tin, iron, barium, lanthanum, titanium, bismuth and copper.
4. The oral composition of claim 1 in which the agent is a methyl vinyl ether/maleic acid or anhydride copolymer or salt thereof.
5. The oral composition of claim 1 in which the agent is polyacrylic acid or salt thereof or gelatin.
6. The oral composition of claim 1 in the form of a dentifrice mouthwash, gel, chewing gum, lozenge or buccal adhesive patch.
7. The oral composition of claim 1 in which the amount of desensitizing agent is about 0.1 to 30% by weight of the composition.
8. The oral composition of claim 10 in which the amount is about 1 to 15% by weight.
9. The oral composition of claim 11 in which the amount is about 2 to 12% by weight.
10. A tooth desensitizing composition comprising at least one water soluble or water swellable polyelectrolyte, together with an acceptable carrier therefore.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/811,811 US5270031A (en) | 1991-12-20 | 1991-12-20 | Dentinal desensitizing compositions |
US811,811 | 1991-12-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2085975A1 CA2085975A1 (en) | 1993-06-21 |
CA2085975C true CA2085975C (en) | 1999-03-30 |
Family
ID=25207656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002085975A Expired - Fee Related CA2085975C (en) | 1991-12-20 | 1992-12-21 | Dentinal desensitizing compositions |
Country Status (15)
Country | Link |
---|---|
US (3) | US5270031A (en) |
EP (1) | EP0549281B1 (en) |
JP (1) | JP2821967B2 (en) |
KR (1) | KR0169140B1 (en) |
AT (1) | ATE178786T1 (en) |
AU (1) | AU655695B2 (en) |
BR (1) | BR9204695A (en) |
CA (1) | CA2085975C (en) |
DE (1) | DE69228922T2 (en) |
DK (1) | DK0549281T3 (en) |
ES (1) | ES2133309T3 (en) |
GR (1) | GR3030422T3 (en) |
MX (1) | MX9207317A (en) |
NZ (1) | NZ245459A (en) |
PH (1) | PH30209A (en) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374417A (en) * | 1991-10-17 | 1994-12-20 | Colgate Palmolive Company | Desensitizing dentifrice |
US5240697A (en) * | 1991-10-17 | 1993-08-31 | Colgate-Palmolive Company | Desensitizing anti-tartar dentifrice |
US5270031A (en) * | 1991-12-20 | 1993-12-14 | Block Drug Company Inc. | Dentinal desensitizing compositions |
US5340370A (en) * | 1993-11-03 | 1994-08-23 | Intel Corporation | Slurries for chemical mechanical polishing |
ES2164753T3 (en) * | 1993-11-15 | 2002-03-01 | Block Drug Co | ORGANOLEPTICALLY STABLE TABLETS FOR CLEANING DENTURES. |
US5505933A (en) * | 1994-06-27 | 1996-04-09 | Colgate Palmolive Company | Desensitizing anti-tartar dentifrice |
US5874066A (en) * | 1994-08-01 | 1999-02-23 | University Of Maryland, Baltimore | Method and kit for treating tooth hypersensitivity |
JPH10505831A (en) * | 1994-09-15 | 1998-06-09 | ザ、プロクター、エンド、ギャンブル、カンパニー | Oral composition |
US5547657A (en) * | 1994-10-11 | 1996-08-20 | Eastman Chemical Company | Low-irritation anesthetic and antiseptic mouth rinse |
US5589159A (en) * | 1995-04-11 | 1996-12-31 | Block Drug Company Inc. | Dispersible particulate system for desensitizing teeth |
GB9515597D0 (en) * | 1995-07-29 | 1995-09-27 | Procter & Gamble | Oral compositions |
US5693315A (en) * | 1996-06-10 | 1997-12-02 | Abco Trust | Mammal tooth treating composition |
US5885551A (en) * | 1997-08-01 | 1999-03-23 | Smetana; Alfred J. | Treatment for dentinal hypersensitivity |
US6096292A (en) * | 1998-07-28 | 2000-08-01 | Block Drug Company, Inc. | Polymeric desensitizing compositions |
US6458339B1 (en) | 2000-02-11 | 2002-10-01 | Charles F. Cox | Acid resistant film forming dental composition and method of use |
US6241972B1 (en) | 1999-02-19 | 2001-06-05 | Block Drug Company, Inc. | Oral care formulation for the treatment of sensitivity teeth |
US6592853B2 (en) * | 1999-03-10 | 2003-07-15 | Block Drug Company, Inc. | Dentin desensitizer containing stannous fluoride |
NZ524610A (en) | 1999-03-12 | 2004-09-24 | Pfizer Prod Inc | Composition containing a soluble potassium salt, a sodium alkylsulphonate, a polar surfactant and a carrier, use as a toothpaste, oral rinse, skin detergent, shampoo, hard surface cleaner and a fabric detergent |
PL356027A1 (en) * | 1999-12-03 | 2004-06-14 | Gaba International Ag | Oral hygiene agents containing amine hydrofluoride |
US20070059257A1 (en) * | 2000-08-18 | 2007-03-15 | Block Drug Company, Inc. | Dentinal composition for hypersensitive teeth |
EP1331919A4 (en) * | 2000-08-21 | 2005-11-16 | Block Drug Co | Dental composition for hypersensitive teeth |
EP1731132B1 (en) | 2000-10-13 | 2008-12-10 | Block Drug Company, Inc. | Dental compositions for hypersensitive teeth |
EP1333796A4 (en) | 2000-10-13 | 2004-12-01 | Block Drug Co | Anhydrous dentifrice formulations for the delivery of incompatible ingredients |
US6416745B1 (en) | 2001-05-03 | 2002-07-09 | Block Drug Company, Inc. | Dental composition for treating hypersensitive teeth |
KR20030006788A (en) * | 2001-07-16 | 2003-01-23 | 이승진 | Sustained release polymeric preparation for treatment of periodontal disease |
DE10312173A1 (en) * | 2003-03-19 | 2004-09-30 | Ingo Hornung | Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac |
JP4962850B2 (en) * | 2004-04-26 | 2012-06-27 | 独立行政法人国立循環器病研究センター | Nerve transmission switching material |
BRPI0512478A (en) * | 2004-07-02 | 2008-03-11 | Discus Dental Impressions Inc | prescription fluoride treatment composition |
CA2587044C (en) * | 2004-11-09 | 2014-04-15 | Discus Dental Impressions, Inc. | Two component dental whitening compositions |
JP5179705B2 (en) * | 2005-03-31 | 2013-04-10 | 三星食品株式会社 | Novel candy composition and novel candy using the same |
US8263143B2 (en) | 2005-08-22 | 2012-09-11 | Kraft Foods Global Brands Llc | Degradable chewing gum |
US8282971B2 (en) | 2005-08-22 | 2012-10-09 | Kraft Foods Global Brands Llc | Degradable chewing gum |
US8268371B2 (en) | 2005-08-22 | 2012-09-18 | Kraft Foods Global Brands Llc | Degradable chewing gum |
ES2432217T3 (en) * | 2005-11-18 | 2013-12-02 | Intercontinental Great Brands Llc | Degradable chewing gum |
US20070183989A1 (en) * | 2005-12-21 | 2007-08-09 | Michael Prencipe | Oral Compositions Comprising Zinc Citrate and/or Tocopherol Agents |
US20070140990A1 (en) | 2005-12-21 | 2007-06-21 | Nataly Fetissova | Oral Compositions Comprising Propolis |
US20070140992A1 (en) * | 2005-12-21 | 2007-06-21 | Lynn Schick | Taste masking of essential oils using a hydrocolloid |
JP5038331B2 (en) | 2006-02-03 | 2012-10-03 | ジェイアール ケム エルエルシー | Anti-aging treatment using copper and zinc composition |
US7897800B2 (en) * | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
EP1993568A2 (en) * | 2006-02-23 | 2008-11-26 | The Research Foundation Of State University Of New York | Method of treating periodontitis and of reducing dentinal sensitivity |
US20070218018A1 (en) * | 2006-03-15 | 2007-09-20 | Discus Dental Impressions, Inc. | Sensitivity relief gel |
US20070243142A1 (en) * | 2006-04-12 | 2007-10-18 | Discko John J | Dental liquid desensitizing preparation with resistant flow |
US8900558B2 (en) * | 2006-06-30 | 2014-12-02 | Colgate-Palmolive Company | High fluoride ion oral care composition and method for maintaining anticaries activity |
US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
DE102006046952A1 (en) | 2006-10-04 | 2008-04-10 | Ley, Fritz, Dr. | Dental, in particular remineralizing and pain-sensitive teeth effective composition and dental particles, in particular for the composition |
US20080268001A1 (en) * | 2007-04-30 | 2008-10-30 | Lynette Zaidel | Oral care composition to reduce or eliminate dental sensitivity |
WO2008145475A1 (en) * | 2007-05-31 | 2008-12-04 | Unilever Plc | Oral care composition |
WO2009067237A1 (en) * | 2007-11-20 | 2009-05-28 | Sasi Kumar Sunkara | Formulation and method for treatment of teeth |
US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
GB0801836D0 (en) * | 2008-01-31 | 2008-03-05 | Glaxo Group Ltd | Novel composition |
JP6034549B2 (en) | 2008-02-08 | 2016-11-30 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | Oral care products and methods of use and manufacture thereof |
AU2012204031B2 (en) * | 2008-02-08 | 2013-09-05 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
CA2750636C (en) | 2009-01-23 | 2017-07-25 | Jr Chem, Llc | Rosacea treatments and kits for performing them |
US20110008271A1 (en) * | 2009-07-13 | 2011-01-13 | Jr Chem, Llc | Rosacea treatments using polymetal complexes |
GB0912768D0 (en) | 2009-07-22 | 2009-08-26 | Glaxo Group Ltd | Novel composition |
US9968803B2 (en) | 2009-10-29 | 2018-05-15 | Colgate-Palmolive Company | Low water stannous fluoride plus zinc citrate dentifrice with improved stability, rheology, and efficacy |
CN103200994B (en) | 2010-01-29 | 2016-02-10 | 高露洁-棕榄公司 | For the oral care product of sensitive enamel nursing |
US8658139B1 (en) | 2010-02-27 | 2014-02-25 | Squigle, Inc. | Prevention and treatment of oral diseases |
US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
GB201105408D0 (en) | 2011-03-30 | 2011-05-11 | Glaxo Group Ltd | Composition |
CA2858743C (en) | 2011-12-20 | 2019-05-07 | Colgate-Palmolive Company | Oral care compositions |
MX352730B (en) * | 2012-12-21 | 2017-12-06 | Gaba Int Holding Ag | Oral care composition. |
WO2015065968A1 (en) | 2013-10-28 | 2015-05-07 | The Procter & Gamble Company | Oral care compositions for tooth desensitizing |
US9927422B2 (en) | 2014-05-13 | 2018-03-27 | The Procter & Gamble Company | Method and device for measuring dentin permeability |
KR102076268B1 (en) * | 2015-04-17 | 2020-02-11 | 주식회사 엘지생활건강 | Oral composition |
WO2016167600A1 (en) * | 2015-04-17 | 2016-10-20 | 주식회사 엘지생활건강 | Oral composition |
RU2595875C1 (en) * | 2015-09-17 | 2016-08-27 | Игорь Иванович Зоткин | Use of zinc or copper (ii) salt as component of oral care composition and oral care composition |
MX2018006087A (en) * | 2015-11-20 | 2018-08-24 | Colgate Palmolive Co | Oral care composition comprising chitosan and silica. |
EA037204B1 (en) | 2016-04-18 | 2021-02-19 | Юнилевер Н.В. | Oral care composition |
EA039435B1 (en) | 2016-04-18 | 2022-01-27 | ЮНИЛЕВЕР АйПи ХОЛДИНГС Б.В. | Oral care product |
GB201607518D0 (en) * | 2016-04-29 | 2016-06-15 | Andalay Technologies Ltd | Mouthwash composition |
WO2021078685A1 (en) | 2019-10-23 | 2021-04-29 | Unilever Ip Holdings B.V. | Method of reducing dental hypersensitivity |
EP3888622A1 (en) | 2020-04-02 | 2021-10-06 | Unilever Global IP Ltd | Oral care system |
EP3888623A1 (en) | 2020-04-02 | 2021-10-06 | Unilever Global IP Ltd | Oral care system |
EP3888620A1 (en) | 2020-04-02 | 2021-10-06 | Unilever Global IP Ltd | Oral care system |
CN114469989A (en) * | 2022-03-15 | 2022-05-13 | 北京大学口腔医学院 | Cationic hydrogel for tooth desensitization and preparation method and application thereof |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1069832B (en) * | 1956-03-01 | 1959-11-26 | Raion-Hamigaki Kabushiki Kaisha (Lion Dentifrice Co., Ltd.) Tokio | Transparent toothpaste and method of making it |
US3003988A (en) * | 1958-10-16 | 1961-10-10 | Clark Cleveland Inc | Stabilizer for dentures |
US3122483A (en) * | 1960-07-21 | 1964-02-25 | Block Drug Co | Strontium ion toothpaste |
GB1055784A (en) * | 1963-06-21 | 1967-01-18 | Unilever Ltd | Polishing agent |
DE1807299A1 (en) * | 1968-11-06 | 1970-06-04 | Bayer Ag | Dentifrices containing exchange resins, dental aids, tooth filling compounds, tooth varnishes and other products that come into contact with living teeth |
DE2164383A1 (en) * | 1971-02-12 | 1972-08-17 | Bartheld, Frits van, Dr., Utrecht (Niederlande) | Agents with the demineralization of tooth enamel inhibiting or the mineralization of tooth enamel promoting effect and process for the production of this agent |
US3772431A (en) * | 1972-09-21 | 1973-11-13 | W Mlkvy | Effervescent mouthwash tablet |
US3888976A (en) * | 1972-09-21 | 1975-06-10 | William P Mlkvy | Zinc and strontium ion containing effervescent mouthwash tablet |
US3863006A (en) * | 1973-01-29 | 1975-01-28 | Milton Hodosh | Method for desensitizing teeth |
US4138477A (en) * | 1976-05-28 | 1979-02-06 | Colgate Palmolive Company | Composition to control mouth odor |
US4296096A (en) * | 1979-07-05 | 1981-10-20 | Colgate-Palmolive Company | High viscosity dentifrice |
US4407675A (en) * | 1980-03-03 | 1983-10-04 | Milton Hodosh | Composition for preserving dental pulp |
US4343608A (en) * | 1980-03-03 | 1982-08-10 | Milton Hodosh | Compound and method for preserving dental pulp |
US4772470A (en) * | 1985-04-27 | 1988-09-20 | Nitto Electric Industrial Co., Ltd. | Oral bandage and oral preparations |
US4906456A (en) * | 1986-03-20 | 1990-03-06 | Colgate-Palmolive Company | Anticalculus oral composition |
US4931273A (en) * | 1985-09-13 | 1990-06-05 | Colgate-Palmolive Company | Anticalculus oral composition |
US4871531A (en) * | 1986-02-10 | 1989-10-03 | Hartlaub Gregory R | Oral compositions |
US4758630A (en) * | 1986-10-27 | 1988-07-19 | Richardson-Vicks Inc. | Denture stabilizing zinc and strontium salts of ave/ma copolymer |
US5032386A (en) * | 1988-12-29 | 1991-07-16 | Colgate-Palmolive Company | Antiplaque antibacterial oral composition |
CA1322960C (en) * | 1987-02-12 | 1993-10-12 | Domenico Caserio | Dentifrice composition for desensitising sensitive teeth |
US4847070A (en) * | 1987-10-08 | 1989-07-11 | The Procter & Gamble Company | Anticalculus compositions |
US5160737A (en) * | 1988-05-03 | 1992-11-03 | Perio Products Ltd. | Liquid polymer composition, and method of use |
GB8811830D0 (en) * | 1988-05-19 | 1988-06-22 | Unilever Plc | Oral compositions |
US4965067A (en) * | 1988-08-10 | 1990-10-23 | The Proctor & Gamble Company | Oral compositions |
US5139768A (en) * | 1989-01-31 | 1992-08-18 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Dental composition for hypersensitive teeth |
GB8906914D0 (en) * | 1989-03-28 | 1989-05-10 | Beecham Group Plc | Novel compositions |
US5073604A (en) * | 1989-05-04 | 1991-12-17 | Richardson-Vicks, Inc. | Denture stabilizing compositions |
US5011830A (en) | 1989-07-03 | 1991-04-30 | The Proctor & Gamble Company | Oral compositions having improved anticalculus properties containing pyrophosphate and an acrylic acid polymer |
US4992258A (en) * | 1989-10-23 | 1991-02-12 | Colgate-Palmolive Company | Dentrifice composition |
US4960586A (en) | 1989-11-15 | 1990-10-02 | Gillette Canada Inc. | Aqueous stannous fluoride non-abrasive home treatment gel compositions |
US5017363A (en) * | 1989-11-15 | 1991-05-21 | Gillette Canada, Inc. | Stabilized stannous fluoride toothpaste |
AU644618B2 (en) * | 1989-12-28 | 1993-12-16 | G-C Shika Kogyo Kabushiki Kaisha | Odontotherapeutical materials |
US5234971A (en) * | 1989-12-28 | 1993-08-10 | G-C Dental Industrial Corp. | Odontotherapeutical materials |
GB2240473B (en) * | 1990-01-31 | 1994-06-29 | Lion Corp | Liquid dentifrice compositions |
US5013541A (en) * | 1990-04-18 | 1991-05-07 | Conopco, Inc. | Poly(alpha-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions |
US5015467A (en) * | 1990-06-26 | 1991-05-14 | The Procter & Gamble Company | Combined anticalculus and antiplaque compositions |
US5015466A (en) * | 1990-06-26 | 1991-05-14 | The Procter & Gamble Company | Anticalculus compositions using tartrate-succinates |
ES2071336T3 (en) * | 1990-10-25 | 1995-06-16 | Boots Co Plc | Mouthwash |
FR2670383B1 (en) * | 1990-12-17 | 1993-04-09 | Scialom Yves | INTERMEDIATE PRODUCT FOR FIXING FILLING AMALGAMS IN DENTAL CAVITIES. |
US5240509A (en) * | 1991-05-28 | 1993-08-31 | Calgon Corporation | Method for removing solids from systems containing water-based paints |
US5250288A (en) * | 1991-09-13 | 1993-10-05 | Gillette Canada, Inc. | Method for desensitizing teeth |
US5211939A (en) * | 1991-09-13 | 1993-05-18 | Gillette Canada | Method for desensitizing teeth |
US5240569A (en) * | 1991-09-30 | 1993-08-31 | Rockwell International Corporation | Magnetically enhanced electrolysis cell system |
US5240697A (en) * | 1991-10-17 | 1993-08-31 | Colgate-Palmolive Company | Desensitizing anti-tartar dentifrice |
US5270031A (en) * | 1991-12-20 | 1993-12-14 | Block Drug Company Inc. | Dentinal desensitizing compositions |
US5188818A (en) * | 1992-03-30 | 1993-02-23 | Isp Investments Inc. | Toothpaste composition containing strontium salt of maleic anhydride-methyl vinyl ether copolymer |
-
1991
- 1991-12-20 US US07/811,811 patent/US5270031A/en not_active Expired - Lifetime
-
1992
- 1992-12-14 AU AU30141/92A patent/AU655695B2/en not_active Ceased
- 1992-12-14 NZ NZ245459A patent/NZ245459A/en unknown
- 1992-12-16 PH PH45444A patent/PH30209A/en unknown
- 1992-12-16 MX MX9207317A patent/MX9207317A/en unknown
- 1992-12-17 BR BR9204695A patent/BR9204695A/en not_active Application Discontinuation
- 1992-12-18 ES ES92311594T patent/ES2133309T3/en not_active Expired - Lifetime
- 1992-12-18 DE DE69228922T patent/DE69228922T2/en not_active Expired - Fee Related
- 1992-12-18 EP EP92311594A patent/EP0549281B1/en not_active Expired - Lifetime
- 1992-12-18 AT AT92311594T patent/ATE178786T1/en not_active IP Right Cessation
- 1992-12-18 DK DK92311594T patent/DK0549281T3/en active
- 1992-12-19 KR KR1019920024766A patent/KR0169140B1/en not_active IP Right Cessation
- 1992-12-21 CA CA002085975A patent/CA2085975C/en not_active Expired - Fee Related
- 1992-12-21 JP JP4356338A patent/JP2821967B2/en not_active Expired - Fee Related
-
1993
- 1993-12-14 US US08/167,558 patent/US5597552A/en not_active Expired - Lifetime
-
1995
- 1995-05-23 US US08/448,127 patent/US5653964A/en not_active Expired - Lifetime
-
1999
- 1999-06-03 GR GR990401506T patent/GR3030422T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK0549281T3 (en) | 1999-10-25 |
AU3014192A (en) | 1993-06-24 |
EP0549281A1 (en) | 1993-06-30 |
CA2085975A1 (en) | 1993-06-21 |
AU655695B2 (en) | 1995-01-05 |
US5653964A (en) | 1997-08-05 |
ES2133309T3 (en) | 1999-09-16 |
KR930012010A (en) | 1993-07-20 |
GR3030422T3 (en) | 1999-09-30 |
PH30209A (en) | 1997-02-05 |
NZ245459A (en) | 1997-11-24 |
EP0549281B1 (en) | 1999-04-14 |
ATE178786T1 (en) | 1999-04-15 |
BR9204695A (en) | 1993-06-22 |
US5270031A (en) | 1993-12-14 |
DE69228922T2 (en) | 1999-08-26 |
DE69228922D1 (en) | 1999-05-20 |
JPH0665083A (en) | 1994-03-08 |
JP2821967B2 (en) | 1998-11-05 |
MX9207317A (en) | 1993-06-01 |
US5597552A (en) | 1997-01-28 |
KR0169140B1 (en) | 1999-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2085975C (en) | Dentinal desensitizing compositions | |
US20030215401A1 (en) | Dental composition for hypersensitve teeth | |
US6241972B1 (en) | Oral care formulation for the treatment of sensitivity teeth | |
US20070059257A1 (en) | Dentinal composition for hypersensitive teeth | |
JPS61165317A (en) | Oral sanitary composition | |
JPH04334314A (en) | Mouthwash composition for preventing tartar | |
WO2009158564A1 (en) | Composition and method for enhancing flouride uptake using bioactive glass | |
CA2505889A1 (en) | Controlled-dissolving polymeric device for the oral cavity | |
US6096292A (en) | Polymeric desensitizing compositions | |
RU2604667C2 (en) | Oral care compositions | |
US6592853B2 (en) | Dentin desensitizer containing stannous fluoride | |
US20020041852A1 (en) | Dental composition for hypersensitive teeth | |
US9913796B2 (en) | Oral care composition containing pumice and calcium carbonate | |
JPH1017446A (en) | Composition for oral cavity | |
EP3817827A1 (en) | Dentifrice comprising a pvm-ma copolymer and a source of free fluoride ions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed | ||
MKLA | Lapsed |
Effective date: 20101221 |